Toast, Inc. (NYSE:TOST – Get Free Report) CEO Aman Narang sold 2,471 shares of the stock in a transaction that occurred on Tuesday, April 2nd. The stock was sold at an average price of $23.40, for a total value of $57,821.40. Following the transaction, the chief executive officer now owns 1,114,454 shares in the company, […]
Shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report) have been given a consensus recommendation of “Buy” by the five brokerages that are covering the company, MarketBeat reports. Five investment analysts have rated the stock with a buy rating. The average 12-month target price among brokers that have updated their coverage on the stock […]
Acelyrin (NASDAQ:SLRN – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a research report issued to clients and investors on Monday, Benzinga reports. They currently have a $28.00 price objective on the stock. HC Wainwright’s price objective would suggest a potential upside of 328.13% from the company’s previous […]
Piper Sandler reissued their overweight rating on shares of Keros Therapeutics (NASDAQ:KROS – Free Report) in a report issued on Wednesday, Benzinga reports. They currently have a $105.00 price objective on the stock. Several other equities research analysts have also issued reports on the stock. Wedbush reaffirmed an outperform rating and issued a $86.00 price […]